Education
About Us
Working with TipRanks
Follow Us
Mark Oki Insider Profile
4 Followers
Mark Oki, Former SVP, CFO, Secretary at Alexza Pharmaceuticals, holds 127.94K shares in Achieve Life Sciences (Ticker: ACHV), holds 190.00K shares in Aytu BioScience (Ticker: AYTU), holds 12.10K shares in Vivus (Ticker: VVUSQ).
Mark Oki Alexza Pharmaceuticals (ALXA)Former SVP, CFO, Secretary
Alexza Pharmaceuticals (ALXA)
Former SVP, CFO, Secretary
Ranked #61,741 out of 103,606 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-10.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Mark Oki
Mark Oki's Trading History
Alexza Pharmaceuticals
Apr 02, 2013
―
Uninformative Buy
193.38K
$59.14K
Aytu BioScience
Nov 21, 2022
CFO
Uninformative Buy
20.70K
$330.60K
Achieve Life Sciences
Sep 22, 2025
CFO
Uninformative Buy
344.38K
$385.10K
Vivus
Nov 18, 2019
―
Uninformative Buy
1.67K
$1.42K
List of latest transactions for each holding click on a transaction to see Mark Oki's performance on stock
You May Also Like
Mark Oki insider profile FAQ
What is the percentage of profitable transactions made by Mark Oki?
The percentage of profitable transactions made by Mark Oki is 50%.
What is the average return per transaction made by Mark Oki?
The average return per transaction made by Mark Oki is -10.60%.
What stocks does Mark Oki hold?
Mark Oki holds: ALXA, AYTU, ACHV, VVUSQ stocks.
What was Mark Oki’s latest transaction?
Mark Oki latest transaction was an Uninformative Buy of $344.38K.
What was Mark Oki's most profitable transaction?
Mark Oki’s most profitable transaction was an Informative Buy of ACHV stock on March 19, 2025. The return on the trade was 5.60%.
What is Mark Oki's role in Alexza Pharmaceuticals?
Mark Oki's role in Alexza Pharmaceuticals is Former SVP, CFO, Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.